Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178736 | SCV000230877 | uncertain significance | not provided | 2015-01-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000798846 | SCV000938481 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2022-06-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 136 of the SGCG protein (p.Gln136Arg). This variant is present in population databases (rs569816696, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SGCG-related conditions. ClinVar contains an entry for this variant (Variation ID: 197646). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV000798846 | SCV003819953 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2020-03-23 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000798846 | SCV002086097 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2019-11-11 | no assertion criteria provided | clinical testing |